Aethlon Medical Stock Shares Outstanding
| AEMD Stock | USD 1.42 0.02 1.39% |
Aethlon Medical fundamentals help investors to digest information that contributes to Aethlon Medical's financial success or failures. It also enables traders to predict the movement of Aethlon Stock. The fundamental analysis module provides a way to measure Aethlon Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aethlon Medical stock.
The current year's Common Stock Shares Outstanding is expected to grow to about 2.5 M. Aethlon | Shares Outstanding |
Aethlon Medical Company Shares Outstanding Analysis
Aethlon Medical's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Aethlon Medical Shares Outstanding | 2.63 M |
Most of Aethlon Medical's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aethlon Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Aethlon Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Aethlon Medical is extremely important. It helps to project a fair market value of Aethlon Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Aethlon Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aethlon Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aethlon Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Aethlon Shares Outstanding Historical Pattern
Today, most investors in Aethlon Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Aethlon Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Aethlon Medical shares outstanding as a starting point in their analysis.
Aethlon Medical Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Aethlon Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Aethlon Medical has 2.63 M of shares currently outstending. This is 98.54% lower than that of the Health Care Equipment & Supplies sector and 98.5% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 99.54% higher than that of the company.
Aethlon Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aethlon Medical's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aethlon Medical could also be used in its relative valuation, which is a method of valuing Aethlon Medical by comparing valuation metrics of similar companies.Aethlon Medical is currently under evaluation in shares outstanding category among related companies.
Aethlon Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Aethlon Medical from analyzing Aethlon Medical's financial statements. These drivers represent accounts that assess Aethlon Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Aethlon Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 5.2M | 24.5M | 21.5M | 7.8M | 9.0M | 8.5M | |
| Enterprise Value | (4.3M) | 14.7M | 5.2M | (5.5M) | (6.3M) | (6.0M) |
Aethlon Fundamentals
| Return On Equity | -0.98 | ||||
| Return On Asset | -0.47 | ||||
| Operating Margin | (20.47) % | ||||
| Current Valuation | (3.25 M) | ||||
| Shares Outstanding | 2.63 M | ||||
| Shares Owned By Insiders | 1.41 % | ||||
| Shares Owned By Institutions | 1.99 % | ||||
| Number Of Shares Shorted | 18.92 K | ||||
| Price To Earning | (1.14) X | ||||
| Price To Book | 0.52 X | ||||
| Price To Sales | 6.91 X | ||||
| Revenue | 574.25 K | ||||
| Gross Profit | 574.25 K | ||||
| EBITDA | (11.76 M) | ||||
| Net Income | (12.03 M) | ||||
| Cash And Equivalents | 14.92 M | ||||
| Cash Per Share | 0.65 X | ||||
| Total Debt | 1.21 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 9.66 X | ||||
| Book Value Per Share | 2.93 X | ||||
| Cash Flow From Operations | (10.51 M) | ||||
| Short Ratio | 1.81 X | ||||
| Earnings Per Share | (5.01) X | ||||
| Target Price | 25.0 | ||||
| Number Of Employees | 15 | ||||
| Beta | 1.94 | ||||
| Market Capitalization | 3.72 M | ||||
| Total Asset | 17.51 M | ||||
| Retained Earnings | (142.36 M) | ||||
| Working Capital | 13.59 M | ||||
| Current Asset | 817 K | ||||
| Current Liabilities | 1.08 M | ||||
| Net Asset | 17.51 M |
About Aethlon Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aethlon Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aethlon Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aethlon Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aethlon Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aethlon Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aethlon Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with Aethlon Stock
| 0.82 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
Moving against Aethlon Stock
| 0.71 | GCTK | GlucoTrack | PairCorr |
| 0.53 | ELMD | Electromed | PairCorr |
| 0.44 | FEMY | Femasys Financial Report 9th of May 2024 | PairCorr |
The ability to find closely correlated positions to Aethlon Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aethlon Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aethlon Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aethlon Medical to buy it.
The correlation of Aethlon Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aethlon Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aethlon Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aethlon Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Aethlon Medical Piotroski F Score and Aethlon Medical Altman Z Score analysis. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Aethlon Stock analysis
When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is Aethlon Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.01) | Revenue Per Share 0.236 | Quarterly Revenue Growth 42.782 | Return On Assets (0.47) | Return On Equity (0.98) |
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.